Back to Search Start Over

尿液诊断膀胱癌的研究进展.

Authors :
费城
王涛
邵佳亮
张恩承
王翔
Source :
Progress in Modern Biomedicine. Nov2021, Vol. 21 Issue 22, p4396-4400. 5p.
Publication Year :
2021

Abstract

Bladder cancer is a common malignant tumor in the urinary system, the incidence of the disease is increasing year by year, and the recurrence rate is relatively high. Early diagnosis and regular follow-up are the keys to ensure long-term survival of bladder cancer patients. The diagnosis of bladder cancer and follow-up of patients are usually performed by cystoscopy or urine exfoliation cytology. However, the former is more expensive and invasive. The latter has the characteristic of relatively low sensitivity and was limited by the subjective factors of the doctor, there is no urine biomarker that can replace traditional diagnostic methods. Bladder tumors have extensive heterogeneity, and different disease phenotypes have different molecular differences. Therefore, the introduction of urine biomarkers to diagnose the disease and assess the aggressiveness, risk of progression, likelihood of recurrence and prognosis of the disease has important clinical value. In this paper, the current status of urinary biomarkers in the diagnosis of bladder cancer is summarized, and the main research progress in this field is reviewed. [ABSTRACT FROM AUTHOR]

Details

Language :
Chinese
ISSN :
16736273
Volume :
21
Issue :
22
Database :
Academic Search Index
Journal :
Progress in Modern Biomedicine
Publication Type :
Academic Journal
Accession number :
154465176
Full Text :
https://doi.org/10.13241/j.cnki.pmb.2021.22.041